Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide—meta-analysis
Open Access
- 8 October 2019
- journal article
- review article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 33 (11) , 766-774
Abstract
Hypertension is a complex syndrome of multiple hemodynamic, neuroendocrine, and metabolic abnormalities. The goals of treatment in hypertension are to optimally control high blood pressure and to reduce associated cardiovascular morbidity and mortality using the most suitable therapy available. Hydrochlorothiazide (HCTZ) and chlorthalidone (CTLD) are with proven hypertensive effects. The topic of our meta-analysis is to compare the efficacy of HCTZ and CTLD therapy in patient with hypertension. A search of electronic databases PubMed, MEDLINE, Scopus, PsyInfo, eLIBRARY.ru was performed. We chose the random-effects method for the analysis and depicted the results as forest plots. Sensitivity analyses were performed in order to evaluate the degree of significance of each study. Of the 1289 identified sources, only nine trials directly compared HCTZ and CTLD and were included in the meta-analysis. Changes in SBP lead to WMD (95% CI) equal to −3.26 mmHg showing a slight but statistically significant prevalence of CTLD. Results from analyzed studies referring to DBP lead to WMD (95% CI) equal to −2.41 mmHg, which is also statistically significant. During our analysis, we found that there were not enough studies presenting enough data on the effect of CTLD and HCTZ on levels of serum potassium and serum sodium. Our meta-analysis has demonstrated a slight superiority for CTLD regarding blood pressure control. At the same time, the two medications do not show significant differences in their safety profile.Keywords
Funding Information
- Tchaikapharma High Quality Medicines Inc
This publication has 37 references indexed in Scilit:
- Antihypertensive Efficacy of Hydrochlorothiazide vs Chlorthalidone Combined with Azilsartan MedoxomilThe American Journal of Medicine, 2012
- Chlorthalidone Reduces Cardiovascular Events Compared With HydrochlorothiazideHypertension, 2011
- Chlorthalidone: Don’t Call It “Thiazide-Like” AnymoreHypertension, 2010
- Chlorthalidone Decreases Platelet Aggregation and Vascular Permeability and Promotes AngiogenesisHypertension, 2010
- The Choice of Thiazide DiureticsHypertension, 2009
- Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood PressureHypertension, 2006
- ChlorthalidoneHypertension, 2006
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the multiple risk factor intervention trialThe American Journal of Cardiology, 1986
- Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention TrialThe American Journal of Cardiology, 1985